Toronto, Canada, March 09, 2026 – Datametrex AI Limited ( the "Company" or  "Datametrex'') (TSXV: DM) (FSE: D4G) (OTC: DTMXF) is pleased to announce the integration of AI software within its EMR (Electronic Medical Records) system to support physicians at the point of care. These AI-assisted functionalities include automated clinical documentation, intelligent document classification, real-time charting support, and AI-generated patient care planning. The system converts phy

Toronto, Canada, February 23, 2026 – Datametrex AI Limited ( the "Company" or  "Datametrex'') (TSXV: DM) (FSE: D4G) (OTC: DTMXF) is pleased to announce that its wholly owned subsidiary, Paymetrex Payment Solutions Inc. ( “Paymetrex” ) ,  has engaged Pelent Patent Analytics ( “Pelent” ) to enhance and accelerate Paymetrex’s patent licensing and monetization program. The engagement, effective February 13, 2026, integrates Pelent’s AI into Paymetrex’s licensing workflow, suppor

Toronto, Canada, February 18, 2026 – Datametrex AI Limited ( the "Company" or  “Datametrex”) (TSXV: DM) (FSE: D4G) (OTC: DTMXF )  is pleased to announce the receipt of a Purchase Order ( “P.O.” ) from a large Fortune 500 company headquartered in South Korea, with offices across Asia and diversified business interests including consumer retail and other sectors. This validates the performance, scalability, and reliability of its data centre operations and infrastructure solu

Toronto, Canada, February 13, 2026 – Datametrex AI Limited ( the "Company" or  “Datametrex”) (TSXV: DM) (FSE: D4G) (OTC: DTMXF )  is pleased to announce that it has received a Purchase Order ( “P.O.” ) of approximately $500,000 from a major Fortune 500 client based in South Korea for data centre operations and infrastructure solutions on February 6, 2026. With an estimated profit margin of approximately 20%, this P.O. supports Datametrex’s ongoing commercialization of its